rxstat › Shortages › Riluzole
Riluzole shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Riluzole products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 24, 2026.
In shortage since
May 15, 2026
Est. full return
Nov 24, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageMYLAN-RILUZOLE
50MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02390299 · since May 15, 2026, est. end Nov 24, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-RILUZOLE
50MG · TABLET · APOTEX INC
DIN 02352583 · ended Apr 16, 2026 · Disruption of the manufacture of the drug.
ResolvedMYLAN-RILUZOLE
50MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02390299 · ended Dec 5, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-RILUZOLE
50MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02390299 · ended Jan 21, 2025 · Delay in shipping of the drug.
ResolvedAPO-RILUZOLE
50MG · TABLET · APOTEX INC
DIN 02352583 · ended Sep 22, 2022 · Disruption of the manufacture of the drug.
ResolvedMYLAN-RILUZOLE
50MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02390299 · ended Oct 15, 2021 · Disruption of the manufacture of the drug.
ResolvedRILUTEK
50MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02242763 · ended Sep 28, 2021 · Shortage of an inactive ingredient or component.
AvoidedMYLAN-RILUZOLE
50MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02390299 · ended Sep 8, 2021 · Disruption of the manufacture of the drug.
AvoidedMYLAN-RILUZOLE
50MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02390299 · ended Apr 26, 2021 · Disruption of the manufacture of the drug.
ResolvedMYLAN-RILUZOLE
50MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02390299 · ended Mar 26, 2021 · Disruption of the manufacture of the drug.
AvoidedMYLAN-RILUZOLE
50MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02390299 · ended Feb 8, 2021 · Shortage of an active ingredient.
ResolvedAPO-RILUZOLE
50MG · TABLET · APOTEX INC
DIN 02352583 · ended Sep 13, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
Riluzole is currently affected by an active shortage report filed with Health Canada by MYLAN PHARMACEUTICALS ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Riluzole is classified under “OTHER NERVOUS SYSTEM DRUGS” (ATC N07XX).
Recent changes
Common questions
When will Riluzole be back in stock in Canada?
The latest manufacturer estimate is Nov 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Riluzole in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.